DIABETES MELLITUS, TYPE 2
Conditions
Keywords
pharmaceutical care
Brief summary
Evaluation of Pharmaceutical Care Program for Type 2 diabetes mellitus in Dhule Objectives:- 1. To evaluate Pharmaceutical care program in Type2 diabetics. 2. To evaluate the impacts of Pharmaceutical care on quality of life (QOL) in patient with Type-2 Diabetes Mellitus. 3. To study the prevalence of Type2 diabetics cases in Dhule. 4. To study the Assessment of different type of adverse drug reactions (ADRs). In Type2 diabetics. 5. To evaluate the Drug Drug intereaction in Type-2 Diabetes Mellitus. 6. To study the impacts of Pharmaceutical care program on glycemic control in patients with Type-2 Diabetes Mellitus. 7. To study the Drug utilization pattern in Type-2 Diabetes Mellitus in civil hospital Dhule. 8. To compare the efficiency of Pharmaceutical care program and drug in patients with Type-2 Diabetes Mellitus. 9. To study the Pharmaco-economic evaluation in Type-2 Diabetes Mellitus patient's. 10. To increase the patient compliance and positive attitude of patients towards the diabetes disease by counseling.
Detailed description
To evaluate the impacts of Pharmaceutical care on quality of life (QOL) in patient with Type-2 Diabetes Mellitus. To study the prevalence of Type2 diabetics cases in Dhule. To study the Assessment of different type of adverse drug reactions (ADRs). In Type2 diabetics. To evaluate the Drug Drug intereaction in Type-2 Diabetes Mellitus.
Interventions
OTHERPHARMACEUTICAL CARE programe
The pharmaceutical care program was characterized by face to face monthly visits to collect information, register information, prepare plan of care for every health problem; identification of drug therapy problems, communication to prescribers the drug therapy problems identified and education of participants to resolve the drug therapy problems.
OTHERWithout PHARMACEUTICAL CARE programe
Sponsors
TABREJ MUJAWAR
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Inclusion Criteria: * Patients with type 2 diabetes mellitus of either * Patients with HbA1c more than 7% and * Patients with blood sugar level more than 140 mg / dl
Exclusion criteria
* Patient with end stage kidney disease. * Patient with heart failure. * Patient with chronic Diabetes problem and orthopedic problem
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Fasting blood glucose measurements recorded (mg/dl).Postprandial blood glucose Recorded: Fasting blood glucose measurements recorded (mg/dl).Postprandial bloodglucoseRecorded | 24 weeks | Fasting blood glucose measurements recorded (mg/dl).Postprandial blood glucose Recorded Fasting blood glucose measurements recorded (mg/dl).Postprandial blood glucose Recorded fasting blood glucose |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quality of Life score | 24 weeks | Quality of Life score |
Countries
India
Outcome results
None listed